NEOGEN CORP MI false 0000711377 0000711377 2020-04-10 2020-04-10

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 10, 2020

 

NEOGEN CORPORATION

(Exact name of registrant as specified in its charter)

 

MICHIGAN

 

0-17988

 

38-2367843

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

620 Lesher Place Lansing, Michigan

 

48912

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code 517-372-9200

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

 

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 10, 2020, James L. Herbert informed the Board of Directors of the Company that he was resigning as Chairman of the Board, effective immediately. He will continue to serve on Neogen’s Board of Directors until his term expires in October 2020.

Herbert, 79, is a founder of Neogen, and served as the company’s CEO from its founding in 1982 until July 2017, when John Adent was named to the role. Herbert has served on Neogen’s Board since its inception, and had served as its chairman since 2006.

Jim Borel, 64, who has served on Neogen’s Board since 2016, was named Chairman of the Board, effective this date. He retired in 2016 from DuPont, where he was executive vice president and a member of DuPont’s Office of the Chief Executive, with responsibility for the agriculture and food ingredients businesses of DuPont, as well as several corporate functions. Borel has over 42 years of experience in the global agriculture and food industry.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
         
 

99.1

   

Press Release dated April 10, 2020

         
 

104

   

Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NEOGEN CORPORATION

 

 

 

(Registrant)

             

Date: April 14, 2020

 

 

 

 

 

 

/s/ Steven J. Quinlan

 

 

 

Steven J. Quinlan

 

 

 

Vice President & CFO